January 5, 2026 – Talk Bio

Actionable Insights Powered by AI

Biotech’s Groove is Back for 2026: XBI Surges Amid M&A Boom and Lower Rates

3 days ago talkbio0Tagged Bassas da India, Lower Rates, M&A, trends qualifier

biotech; XBI; M&A; lower rates; 2026 trends

Insilico Medicine and Servier Announce Up to $888 Million AI-Driven Oncology R&D Collaboration

4 days ago talkbio0Tagged AI Platform, Drug Discovery, Insilico Medicine, Neoplasms, Pharma, Servier

Insilico Medicine; Servier; AI platform; oncology; drug discovery; Pharma.AI; $888 million

Genelux Corporation Appoints Jason Litten, M.D., as Chief Medical Officer to Advance Olvi-Vec Development

4 days ago talkbio0Tagged Chief Medical Officer, Chronic multifocal osteomyelitis, Clinical Trials, Genelux Corporation, immuno-oncology, Jason Litten

Genelux Corporation; Jason Litten; Chief Medical Officer; CMO; Olvi-Vec; immuno-oncology; clinical trials

Orum Therapeutics Appoints Chad May as Chief Scientific Officer

4 days ago talkbio0Tagged Chad, CSO, decitabine, Degrader-Antibody Conjugates, Month of May, Orum Therapeutics, Targeted Protein Degradation

Orum Therapeutics; Chad May; CSO; Degrader-Antibody Conjugates; DAC; Targeted Protein Degradation

ScinoPharm Taiwan Secures Historic U.S. FDA Approval for Glatiramer Acetate Injection to Treat Multiple Sclerosis

4 days ago talkbio0Tagged Approved, Complex, glatiramer acetate, Multiple Sclerosis, ScinoPharm, Taiwan, United States Food and Drug Administration

ScinoPharm; FDA Approval; Glatiramer Acetate; Multiple Sclerosis; Taiwan; Complex Generic

FDA Clears BrainSpace Intellidrop: Automated Neuro Device Tackling ICU Nursing Shortages and Advancing Physical AI

4 days ago talkbio0Tagged Administration occupational activities, brain fluid, BrainSpace, Clearance, ICU, ICU nursing shortages, Intellidrop, neuro injury, Physical AI, United States Food and Drug Administration

FDA clearance; BrainSpace; Intellidrop; ICU nursing shortages; brain fluid management; Physical AI; neuro injury